Is there a cancer vaccine Brian could look into
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Let me provide guidance based on trusted medical sources while considering Brian's specific case details from the clinical summary:
According to the NCCN Guidelines and NCI recommendations, there are currently no approved therapeutic cancer vaccines specifically for pancreatic adenocarcinoma. However, given Brian's molecular profile from the document, particularly his:
- High PDL1 expression
- MSS (Microsatellite Stable) status
- Immune Desert microenvironment type
The American Society of Clinical Oncology (ASCO) guidelines suggest that patients with metastatic pancreatic cancer may be candidates for clinical trials investigating novel immunotherapy approaches, which could include vaccine studies.
Based on the National Cancer Institute's current clinical trials database, while there are some experimental vaccine trials in pancreatic cancer, any recommendations would need to consider Brian's specific situation:
- His metastatic disease status
- Recent progression on FOLFIRINOX + RMC-6236
- His unique molecular profile including the RAF1 fusion
Important recommendation: Brian should discuss potential immunotherapy or vaccine trial options with his oncology team, particularly since he's already engaged with multiple major cancer centers (Columbia, NYU Langone, MSK) as noted in the clinical summary. His care team can best evaluate his eligibility for any available vaccine trials considering his complete clinical picture.
Remember: This information should be used for discussion with healthcare providers only, as clinical trial eligibility and treatment decisions must be made by his medical team.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ